JDP Global, a leading UK-based venture capital firm, is proud to announce its latest strategic investment in Precision Neuroscience, a pioneering brain-computer
interface (BCI) technology company. This investment marks a significant step toward supporting groundbreaking advancements in neurotechnology and unlocking new possibilities for treating
neurological disorders.
Precision Neuroscience, headquartered in New York City, is developing cutting-edge BCI solutions aimed at transforming the treatment of conditions such as paralysis, stroke, and neurodegenerative diseases. The company’s flagship product, the Layer 7 Cortical Interface, is a minimally invasive neural implant designed to record and stimulate brain activity with unprecedented precision. The technology has the potential to restore mobility and communication abilities for patients suffering from severe neurological impairments.
“Precision Neuroscience is at the forefront of innovation in brain-computer interface technology,” said James O’Connell, Founder of JDP Global. “We are thrilled to support their mission to redefine possibilities in healthcare through advanced neuroscience. This investment reflects our ongoing commitment to backing transformative technologies with the power to improve lives globally.”
JDP Global’s decision to invest in Precision Neuroscience aligns with its strategic focus on high-impact sectors such as healthcare and technology. The firm has a track record of identifying and scaling disruptive businesses, including its previous successful investment in JustPark, a smart parking platform that achieved a successful exit.
The funding will enable Precision Neuroscience to scale its operations, advance clinical studies, and strengthen regulatory pathways, including its ongoing work toward FDA approvals. It also supports the expansion of manufacturing capabilities following the company’s recent acquisition of a microelectromechanical systems (MEMS) production facility in Texas.
With this investment, JDP Global continues to position itself as a key player in the venture capital space, focusing on cutting-edge technologies that merge innovation with societal impact.
